ZELREVV
Live / Applied — Non-final action mailed (as of 18 May 2026)
What this means for you
Not registered yet, but its 26 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99727445
- Mark type
- Word mark
- Filed
- 26 Mar 2026
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer; Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders; Pharmaceutical preparations for use in the treatment of metastatic diseases; Pharmaceutical preparations for treating metabolic diseases and disorders; Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders; Pharmaceutical preparations
Owner
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 18 May 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 May 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2026 — NON-FINAL ACTION E-MAILED
- 18 May 2026 — NON-FINAL ACTION WRITTEN
- 14 May 2026 — ASSIGNED TO EXAMINER
- 26 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Mar 2026 — NEW APPLICATION ENTERED